Pivotal Clinical ApS: Financial statements 2019
CVR: 40343040
Source: annual report 2019, Danish Business Authority
06/03/2019 – 31/12/2019
Pivotal Clinical ApS (CVR 40343040) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK 0. Equity in the 2019 report amounted to DKK 50,000. The solvency ratio was 100%.
- Profit/Loss
- DKK 0
- Equity
- DKK 50,000
- Total Assets
- DKK 50,000
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of March 6, 2019, Ibrahim Naman Farr Juri is registered as director of Pivotal Clinical ApS.
As of March 6, 2019, is registered as an owner of Pivotal Clinical ApS with an ownership share of 100%.
Pivotal Clinical ApS was founded on March 6, 2019.
About Pivotal Clinical ApS
Pivotal Clinical ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ibrahim Naman Farr Juri. The company is owned by Pivotal S.L.. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -75 and a net result of DKK -82 compared with DKK -32 the year before. Equity in the 2025 report amounted to DKK 49,886.